# Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis

> **NCT01922895** · NA · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 45 (actual)

## Conditions studied

- Acute Alcoholic Hepatitis

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus Rhamnosus GG
- **DRUG:** Placebo for Probiotic

## Key facts

- **NCT ID:** NCT01922895
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2021-08-31
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01922895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01922895, "Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01922895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*